Shoukat Dedhar, Ph.D.
British Columbia Cancer Research Centre
Professor, Biochemistry and Molecular Biology, Univ. of British Columbia
Dr Dedhar received his BSc(Hons) in Biochemistry from the University in Aberdeen, Scotland, and his PhD from the University of British Columbia (UBC), Vancouver, Canada in 1984. He carried out a Postdoctoral Fellowship in the laboratory of Dr. Erkki Ruoslahti at the Burnham Institute, in La Jolla, California, USA.
Dr Dedhar is noted for his discovery of Integrin-Linked Kinase (ILK) and his research is currently focused on the role of ILK signaling in cancer progression, the molecular basis and targeting of centrosome clustering in cancer cells, and therapeutic targeting of tumor hypoxia effectors, Carbonic Anhydrases IX and XII.
Dr Dedhar has received several awards, including the Distinguished Scholar award from the Michael Smith Foundation for Health Research (MSFHR), the Terry Fox Cancer Research Scientist award of the National Cancer Institute of Canada (NCIC), the Robert L Noble Prize (2013), for “Outstanding Achievement in Cancer Research”, and the 2016 UBC Distinguished Medical Research Lectureship Award of UBC.
Dr. Dedhar is a recipient of a the prestigious CIHR Foundation Scheme grant and he is an author on 207 peer-reviewed papers and review articles, and an inventor on 24 patents.